Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 458
Immune Disorders Drugs 196
Cardiovascular Drugs 161
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 113
Clinical Trials 107
Central Nervous System Drugs 106
Musculoskeletal Disorders Drugs 98
Pharmaceuticals 96
Leukemia Drugs 82
Hematological Drugs 80
Liver and Kidney Disorders Drugs 76
Lymphoma Drugs 62
Dermatological Drugs 59
Diabetes Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Drug Delivery 36
Pharmaceutical Intermediates 34
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
Prostate Cancer Drugs 18
HIV/AIDS Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Vaccines 8
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

2,424 Results (Page 65 of 122)
- Relevance
  Sort by

Oncology Precision Medicine Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Cancer Targeted, Route of Administration, Type of Molecule, Drug Class, Key Geographical Regions, Leading Drug Developers and Sales Forecast

 Report
February 2024
468 Pages
Global

From

€4270EUR$4,799USD£3,687GBP

Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets

 Report
October 2023
157 Pages
Global

From

€4137EUR$4,650USD£3,572GBP

Regenerative Medicine Market Report 2023-2033

 Report
March 2023
232 Pages
Global

From

€4735EUR$5,508USD£3,950GBP

Central Nervous System Collaboration and Licensing Deals 2020-2025

 Report
April 2025
400 Pages
Global

From

€3554EUR$3,995USD£3,069GBP

Novel T-Cell Immunotherapies Market: Focus on T-Cells, Tregs, Activated T-Cells, Virus-driven T-Cells & T-Cell Vaccines - Distribution by Type of T-Cell Therapy, Target Indications , Key Players and Key Geographies: Industry Trends and Global Forecasts, 2021-2030

 Report
June 2021
193 Pages
Global

From

€4270EUR$4,799USD£3,687GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Pharmaceutical Industry in the United States 2022

 Report
September 2022
150 Pages
United States

From

€756EUR$850USD£653GBP

Live Biotherapeutic Products and Microbiome Manufacturing Market by Type of Product Manufactured, Type of Formulation, Type of Primary Packaging Used, Scale of Operation, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, 2022 - 2035

 Report
February 2022
305 Pages
Global

From

€4270EUR$4,799USD£3,687GBP

Neuropathic Pain - Global Strategic Business Report

 Report
August 2025
386 Pages
Global

From

€5205EUR$5,850USD£4,494GBP

Targeted Protein Degradation - Global Strategic Business Report

 Report
August 2025
384 Pages
Global

From

€5205EUR$5,850USD£4,494GBP

Microbial API - Global Strategic Business Report

 Report
August 2025
466 Pages
Global

From

€5205EUR$5,850USD£4,494GBP

Biopharmaceutical Contract Manufacturing Market by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022 - 2035

 Report
September 2022
799 Pages
Global

From

€4270EUR$4,799USD£3,687GBP

Cardiovascular and Cerebrovascular Diseases Market (2023 Edition): Analysis By Drug Type, By Indication, By Region, By Country: Drivers, Trends and Forecast to 2029

 Report
August 2023
230 Pages
Global

From

€2180EUR$2,450USD£1,882GBP

Active Pharmaceutical Ingredient (API) Market in the US 2025-2029

 Report
May 2025
177 Pages
United States

From

€2224EUR$2,500USD£1,921GBP

Monoclonal Antibody Discovery and Analysis Market Report 2022-2032

 Report
December 2022
437 Pages
Global

From

€4735EUR$5,508USD£3,950GBP

Non-cancerous Skin Diseases Therapeutics Market 2025-2029

 Report
February 2025
222 Pages
Global

From

€2224EUR$2,500USD£1,921GBP

Influenza Vaccine Market by Vaccine Type (Inactivated, Live Attenuated, Recombinant), Age Group (Adult, Geriatric, Pediatric), Dosage, Presentation, Distribution Channel, End User - Global Forecast 2025-2030

 Report
August 2025
186 Pages
Global

From

€3154EUR$3,545USD£2,723GBP

€3504EUR$3,939USD£3,026GBP

Idiopathic Pulmonary Fibrosis (IPF) Market (2023 Edition): Analysis By Drug Type (Pirfenidone, Nintedanib, Others), Route of Administration (Oral, Parenteral, Others), Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
July 2023
260 Pages
Global

From

€2180EUR$2,450USD£1,882GBP

Biologics - Global Strategic Business Report

 Report
August 2025
293 Pages
Global

From

€5205EUR$5,850USD£4,494GBP

Peptide Therapeutics - Global Strategic Business Report

 Report
August 2025
192 Pages
Global

From

€5205EUR$5,850USD£4,494GBP

Biological Drugs - Global Strategic Business Report

 Report
August 2025
196 Pages
Global

From

€5205EUR$5,850USD£4,494GBP

2,424 Results (Page 65 of 122)
- 1
- 63
- 64
- 65
- 66
- 67

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.